First Trust NYSE Arca Biotechnology Index Fund (FBT)
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
$3.65B
Jun 19, 2006
20.40
$8.57
0.00
0.00
1.71%
0.00%
0.00
0.00
0.00
0.00
0.00%
0.00%
ETF Constituents (22)
Exelixis, Inc.
EXEL
4.463%
Corcept Therapeutics Incorporated
CORT
4.205%
Incyte Corporation
INCY
3.989%
ACADIA Pharmaceuticals Inc.
ACAD
3.961%
Intra-Cellular Therapies, Inc.
ITCI
3.91%
Catalyst Pharmaceuticals, Inc.
CPRX
3.755%
Halozyme Therapeutics, Inc.
HALO
3.729%
Gilead Sciences, Inc.
GILD
3.695%
Neurocrine Biosciences, Inc.
NBIX
3.562%
Illumina, Inc.
ILMN
3.367%
Natera, Inc.
NTRA
3.332%
Repligen Corporation
RGEN
3.251%
Alnylam Pharmaceuticals, Inc.
ALNY
3.184%
Amgen Inc.
AMGN
3.17%
BioMarin Pharmaceutical Inc.
BMRN
3.052%
Biogen Inc.
BIIB
2.954%
Bruker Corporation
BRKR
2.839%
BeiGene, Ltd.
BGNE
2.809%
Mettler-Toledo International Inc.
MTD
2.787%
Regeneron Pharmaceuticals, Inc.
REGN
2.63%
Moderna, Inc.
MRNA
2.372%
Exact Sciences Corporation
EXAS
2.34%
ETF Constituents (22)
Exelixis, Inc.
EXEL
4.463%
Corcept Therapeutics Incorporated
CORT
4.205%
Incyte Corporation
INCY
3.989%
ACADIA Pharmaceuticals Inc.
ACAD
3.961%
Intra-Cellular Therapies, Inc.
ITCI
3.91%
Catalyst Pharmaceuticals, Inc.
CPRX
3.755%
Halozyme Therapeutics, Inc.
HALO
3.729%
Gilead Sciences, Inc.
GILD
3.695%
Neurocrine Biosciences, Inc.
NBIX
3.562%
Illumina, Inc.
ILMN
3.367%
Natera, Inc.
NTRA
3.332%
Repligen Corporation
RGEN
3.251%
Alnylam Pharmaceuticals, Inc.
ALNY
3.184%
Amgen Inc.
AMGN
3.17%
BioMarin Pharmaceutical Inc.
BMRN
3.052%
Biogen Inc.
BIIB
2.954%
Bruker Corporation
BRKR
2.839%
BeiGene, Ltd.
BGNE
2.809%
Mettler-Toledo International Inc.
MTD
2.787%
Regeneron Pharmaceuticals, Inc.
REGN
2.63%
Moderna, Inc.
MRNA
2.372%
Exact Sciences Corporation
EXAS
2.34%